[ET Net News Agency, 27 October 2023] EVEREST MED-B (01952) rose 10.2% to HK$24.35.
It hits an intra-day high of HK$24.35, and an intra-day low of HK$21.65, hitting an
1-month low. The total shares traded was 3.81 million, with a value of HK$88.87m. The
active buy/sell ratio is 69:31, with net buying turnover of HK$32.51m. HSBC SEC BRO (ASIA)
accounts for greatest net responsive buying turnover of HK$468,728, with volume weighted
average price of HK$22.954. CITIGROUP GLOBAL accounts for greatest net responsive selling
turnover of HK$10.5m, with volume weighted average price of HK$23.443.
Basic Information
=================
----------------------------------
Nominal 24.350 % Chg +10.18%
High 24.350 Low 21.650
Shares Tr 3.81m Turnover 88.87m
10-D SMA 24.720 %H.V 61.501
20-D SMA 24.738 VWAP 23.306
50-D SMA 21.155 RSI14 54.371
----------------------------------
Status: Hitting an 1-month low, active buy/sell ratio is 69:31, with net buying turnover
of HK$32.51m
Performance of stocks in the same sector or of relevance
========================================================
Stock (Code) Price (HK$) Change (%)
---------------------------------------------
EVEREST MED-B (01952) 24.35 +10.18
GENSCRIPT BIO (01548) 20.80 +5.48
INNOVENT BIO (01801) 44.45 +5.08
WUXI BIO (02269) 46.85 +5.28
WUXI APPTEC (02359) 96.55 +4.66
BEIGENE (06160) 104.00 +4.52
ASCENTAGE-B (06855) 23.35 +5.66
ZAI LAB (09688) 18.84 +2.28
AKESO (09926) 40.25 +3.47
ALPHAMAB-B (09966) 10.94 +7.89
---------------------------------------------
(ed)